Uppsala Antibiotic Center

Every day, antibiotics save many lives all over the world. They have become indispensable in contexts ranging from basic healthcare to advanced medicine. But what will happen if antibiotics stop working? Developing new, globally available antibiotics is not just a public health issue and limiting the spread of antibiotic resistance, it is also a critical factor for a globalised society. A new centre at Uppsala University is now bringing the combined forces of research, education and innovation from different scientific disciplines to bear on the challenge of seeking solutions to antibiotic resistance.

Antibiotic resistance is a rapidly growing problem. Each year in the U.S., at least 2 million people get an antibiotic-resistant infection, and at least 23,000 people die from these infections where antibiotics are no longer effective. The annual number of global deaths has already reached 700,000 and by 2050 this figure may have increased to 10 million deaths at a cost approaching USD 100 trillion.

Sooner or later, bacteria develop resistance to all antibiotics. This means that new anti-infectious products need to be developed all the time. However, pharmaceutical development is a protracted process that requires stable funding to maintain expertise and develop effective procedures. There is now a great and urgent need to stimulate research that can identify completely new antibacterial substances and to find alternative modes of antibacterial pharmaceutical development. Simultaneously, we need to develop methods and policies that will limit the speed with which antibiotic resistance increases today.

Uppsala University has built up a successful platform for antibiotics development. In addition to strong basic research in pharmaceutical development, microbiology and antibiotic resistance the University conducts internationally outstanding research in diagnostics, new financial models, law, clinical research, ethics, global health, sustainable development, behaviour and learning. The University also leads several major international, EU-funded research projects in the area of antibiotics. Several projects and networks operating here aim to find solutions to the growing problems associated with antibiotic resistance.

Uppsala Antibiotic Center is a new centre at Uppsala University for research, education and innovation focused on tackling and finding solutions to the global challenge of antibiotic resistance. The research aims for deeper knowledge on the development of resistance by bacteria, the use of available antibiotics and the development of new antibiotics. The centre gathers researchers from Uppsala University's all scientific domains in a unique effort to preserve the much needed capacity of antibiotics to safeguard human and animal health.

Support research on antibiotic resistance

Last modified: 2021-03-08